Skip to main content
. 2015 Oct 21;7(1):56–61. doi: 10.1007/s13193-015-0479-8

Table 2.

Surgical treatment, histopathology and immunohistochemistry (IHC) details

Case no Surgical procedure Histopathology/mitosis per HPF IHC CD-117 CD-34 DOG-1
1 Tumor debulking with resection anastomosis of jejunum Ileal GIST, mitotic rate > 5/50 + +
2 Laparotomy with segmental resection of ileum with end to end anastomosis Ileal GIST, mitotic rate > 5/50 +
3 Laparotomy with removal of ileal tumor and end to end anastomosis Ileal GIST, mitotic rate > 5/50 +
4 Laparotomy with tumor debulking with THA and BSO Mesentric GIST, mitotic rate > 5/50 + +
5 Ileal mass excision with anastomosis Ileal GIST, mitotic rate > 5/50 + +
6 Resection of ileal tumor with anastomosis Ileal GIST, mitotic rate > 5/50 + + +
7 Laparotomy, resection of jejunal tumor and end to end anastomosis jejunal GIST, mitotic rate > 5/50 +
8 Laparotomy with resection of ileal tumor, with anastomosis of ileum Ileal GIST, mitotic rate < 5/50 + +
9 Sigmoidectomy with colorectal anastomosis Sigmoid GIST, mitotic rate > 5/50 + + +
10 Resection of ileal mass with End to end anastomosis Ileal GIST, mitotic rate < 5/50 + +

GIST Gastrointestinal stromal tumor; HPF high power field; TAH Total abdominal hysterectomy; BSO Bilateral salphingo oopharectomy; IHC Immunohistochemistry; CD Cluster differentiation; DOG Detected on GIST